Immage Biotherapeutics Corp Stock Fundamentals
Immage Biotherapeutics Corp fundamentals help investors to digest information that contributes to Immage Biotherapeutics' financial success or failures. It also enables traders to predict the movement of Immage Stock. The fundamental analysis module provides a way to measure Immage Biotherapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Immage Biotherapeutics stock.
Immage |
Immage Biotherapeutics Corp Company Current Valuation Analysis
Immage Biotherapeutics' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Immage Biotherapeutics Current Valuation | 32.93 K |
Most of Immage Biotherapeutics' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Immage Biotherapeutics Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Immage Biotherapeutics Corp has a Current Valuation of 32.93 K. This is much higher than that of the sector and significantly higher than that of the Current Valuation industry. The current valuation for all United States stocks is notably lower than that of the firm.
Immage Biotherapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Immage Biotherapeutics's current stock value. Our valuation model uses many indicators to compare Immage Biotherapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Immage Biotherapeutics competition to find correlations between indicators driving Immage Biotherapeutics's intrinsic value. More Info.Immage Biotherapeutics Corp is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Immage Biotherapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Immage Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Immage Biotherapeutics' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Immage Biotherapeutics could also be used in its relative valuation, which is a method of valuing Immage Biotherapeutics by comparing valuation metrics of similar companies.Immage Biotherapeutics is currently under evaluation in current valuation category among its peers.
Immage Fundamentals
| Return On Equity | -11.34 | |||
| Return On Asset | -4.96 | |||
| Current Valuation | 32.93 K | |||
| Shares Outstanding | 151.74 M | |||
| Shares Owned By Insiders | 69.85 % | |||
| Price To Earning | (0.01) X | |||
| EBITDA | (1.82 M) | |||
| Net Income | (216.48 K) | |||
| Cash And Equivalents | 53.69 K | |||
| Debt To Equity | 2.52 % | |||
| Current Ratio | 0.83 X | |||
| Cash Flow From Operations | (215.82 K) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | 56.14 | |||
| Market Capitalization | 151 | |||
| Total Asset | 243.1 K | |||
| Working Capital | 17 K | |||
| Current Asset | 75 K | |||
| Current Liabilities | 58 K | |||
| Z Score | -24.62 | |||
| Net Asset | 243.1 K |
About Immage Biotherapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Immage Biotherapeutics Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immage Biotherapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immage Biotherapeutics Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Immage Biotherapeutics Corp. does not have significant business operations. Immage Biotherapeutics Corp. is a subsidiary of Coventry International Limited. IMMAGE BIOTHERAPEUTICS is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Immage Stock
If you are still planning to invest in Immage Biotherapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Immage Biotherapeutics' history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |